LIFECORE BIOMEDICAL, INC. Gain (Loss) on Disposition of Property (Deprecated 2013-01-31)
LIFECORE BIOMEDICAL, INC. (LFCR) reported Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) of -$217.00 thousand for the 12-month period ending 2013-05-26, per its 10-K filed 2013-08-07.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfProperty · last filed 2013-08-07
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property (deprecated 2013-01-31) for the quarter ending 2013-05-26 was -$37.00K.
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property (deprecated 2013-01-31) for the quarter ending 2013-02-24 was $0.00.
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property (deprecated 2013-01-31) for the quarter ending 2012-11-25 was $0.00.
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property (deprecated 2013-01-31) for the quarter ending 2012-08-26 was -$180.00K.
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property (deprecated 2013-01-31) for fiscal 2013 was -$217.00K.
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property (deprecated 2013-01-31) for fiscal 2012 was -$12.00K.
- LIFECORE BIOMEDICAL, INC. gain (loss) on disposition of property (deprecated 2013-01-31) for fiscal 2011 was -$26.00K.
| Period end | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) 3 month | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) 3 month as first filed | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) 6 month | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) 9 month | Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|---|
| 2013-05-26 | -$37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | -$37.00K derived: sum of 2 quarters · filed 2013-08-07 | -$37.00K derived: sum of 3 quarters · filed 2013-08-07 | -$217.00K 10-K · filed 2013-08-07 | |
| 2013-02-24 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | $0.00 derived: sum of 2 quarters · filed 2013-04-04 | -$180.00K 10-Q · filed 2013-04-04 | ||
| 2012-11-25 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | -$180.00K 10-Q · filed 2013-01-04 | |||
| 2012-08-26 | -$180.00K 10-Q/A · filed 2013-01-02 | $180.00K 10-Q · filed 2012-10-03 | |||
| 2012-05-27 | -$12.00K 10-K · filed 2013-08-07 | ||||
| 2011-05-29 | -$26.00K 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |